CN100415283C - Medicine for resisting inflammation, contracting uterus and eliminating tumor and its prepn process - Google Patents
Medicine for resisting inflammation, contracting uterus and eliminating tumor and its prepn process Download PDFInfo
- Publication number
- CN100415283C CN100415283C CNB2004100320167A CN200410032016A CN100415283C CN 100415283 C CN100415283 C CN 100415283C CN B2004100320167 A CNB2004100320167 A CN B2004100320167A CN 200410032016 A CN200410032016 A CN 200410032016A CN 100415283 C CN100415283 C CN 100415283C
- Authority
- CN
- China
- Prior art keywords
- medicine
- herba
- hysteromyoma
- present
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a drug for resisting inflammation, contracting uterus and eliminating tumors, which uses cherokee rose fruits, Herba Scutellariae Barbatae, cassia twig, red halloysite, motherwort, tuckahoe, fresh oyster shell, selfheal, trigone, herba artemisiae, wide morinda officinalis, madder, radix cyathulae, deglued antler and zedoary as raw materials. The Chinese medicinal materials are soaked in water when preparing, juice can be obtained by decocting, supernatant can be obtained by distilling, refluxing, filtering, clarifying and is bagged in a bottle in an autoclaving mode so as to make oral liquid. The medicine of the present invention has efficacies of glechomapromoting blood circulation to remove blood, softening and resolving hard mass, antiinflammatory, hemostasis, leucorrhoea stop and the shrinkage of uteri; the present invention can tonify and nourish the kidneys. The present invention can be used for treating woman's diseases, such as hysteromyoma, large numbers of menstrual blood volume, the pain of waists and abdomens in menstrual period, and large numbers of leucorrhoea.
Description
One, technical field
The present invention relates to a kind of treatment hysteromyoma, concurrent menorrhagia, menstrual period waist abdomen pain, the many medicines of leucorrhea amount.Be the Chinese patent medicine of feedstock production specifically, the invention still further relates to the preparation method of this medicine with the Chinese herbal medicine.
Two, background technology
Hysteromyoma is women's commonly encountered diseases and frequently-occurring disease at present, if can not get correctly controlling and preventing in early days, its development is very fast, and the danger of cancerating is arranged.When increasing to certain degree, the uterus muscular tumor must go operative treatment, even the row panhysterectomy.Very big to women's body and mind wound.The diagnosis of hysteromyoma is called the “ mass in the abdomen in the traditional Chinese medical science ", belong to miscellaneous gynecological diseases, think the many and deficiency of vital QI of formation of Qi mass in the abdomen, the vim and vigour imbalance is relevant, commonly forms so that factors such as qi depression to blood stasis, phlegm resistance knot is poly-.Doctor trained in Western medicine thinks that then the generation of hysteromyoma and long-term a large amount of estrogen stimulations that continue have relation.With the passing of time hysteromyoma influences the normal contractile function in uterus, easily causes menorrhagia, menstrual period waist abdomen pain, and the with the passing of time concurrent hemorrhagic anemia of severe loss of blood, leucorrhea amount are many etc., if untimelyly effectively treat early, the danger that hysterectomizes is arranged.
Three, summary of the invention
The purpose of this invention is to provide a kind of blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, antiinflammatory hemostasis leukorrhagia stopping, shrink the uterus, kidney is supported in the kidney invigorating, treatment hysteromyoma, concurrent menorrhagia, menstrual period waist abdomen pain, the many therapeutic agents of leucorrhea amount.
Another object of the present invention provides the preparation method of this therapeutic agent.
Medicine of the present invention is made by following component: (consumption is a weight portion)
Fructus Rosae Laevigatae 30---45 Herba Scutellariae Barbatae 15---30 Ramulus Cinnamomi 18---25
Halloysitum Rubrum 20---30 Herba Leonuri 15---30 Poria 15---20
Concha Ostreae 45---60 Spica Prunellae 15---30 rhizoma sparganic 10---20
Herba Artemisiae Anomalae 15---30 extensively clings to halberd 10---15 Radix Rubiae 10---15
River cattle sunset 10---15 Cornu Cervi Degelatinatum 10---20 Rhizoma Curcumae 15---20
Medicine production method of the present invention is: with Fructus Rosae Laevigatae, Herba Scutellariae Barbatae, Ramulus Cinnamomi, Halloysitum Rubrum, Herba Leonuri, Poria, Concha Ostreae, Spica Prunellae, rhizoma sparganic, Herba Artemisiae Anomalae, extensively cling to halberd, Radix Rubiae, river Niu Xi, Cornu Cervi Degelatinatum, Rhizoma Curcumae and be soaked in water 2-3 hour; After the immersion, after the decoction boiling for the first time, slow fire continues to decoct extracting juice after 30 minutes; After for the second time decocting with water boiling, slow fire continues to decoct extracting juice after 30 minutes; Twice decoction medicinal liquid mixed,, get the bottling of supernatant autoclaving, make oral liquid through distillation, backflow, filtration, clarification.
The performance that relates to medical herbs in the pharmaceutical formulation of the present invention is: Herba Artemisiae Anomalae, Radix Rubiae, Rhizoma Curcumae, rhizoma sparganic are principal agent, blood circulation promoting and blood stasis dispelling; Concha Ostreae, Spica Prunellae, Ramulus Cinnamomi, Poria, be accessory drugs, hard masses softening and resolving; Herba Scutellariae Barbatae, Halloysitum Rubrum, Fructus Rosae Laevigatae anti-inflammation hemostasia leukorrhagia stopping; Herba Leonuri, river cattle sunset are shunk the uterus; Cornu Cervi Degelatinatum, extensively cling to the halberd the kidney invigorating and support kidney.All medicines share, the effect of have blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, antiinflammatory hemostasis leukorrhagia stopping, shrink the uterus, kidney is supported in the kidney invigorating.
Using method: medicinal preparation for oral administration of the present invention, every day three times, each 100-150ml, the treatment menorrhagia, 5--7 days is a course of treatment; The dispersing tumor 2-3 month is a course of treatment.The careful estrogen of using of forbidding avoids pungent food and drinks during taking.
In order to show that the present invention has treatment hysteromyoma, concurrent menorrhagia, menstrual period waist abdomen pain, the many effects of leucorrhea amount are divided into test group 150 examples at random with 210 routine patients, matched group 60 examples, two groups of ages, symptom, courses of disease no significant difference of comparing has comparability.
Diagnostic criteria: try out in the teaching material " obstetrics and gynecology " according to People's Health Publisher's national high medical college that publish and distribute, the chief editor of Shanghai first medical college Tianjin Medical College in 1980, the identification of hysteromyoma, and the Luo Yuankai chief editor's of reference Shanghai science tech publishing house publication in 1986 higher medical universities and colleges teaching materials " Gynecology of Chinese Medicine " mass in the abdomen is dialectical.The hysteromyoma size is treatment target below 4cm, need operative treatment not in therapeutic domain.
Therapeutic Method: test group is used medicinal preparation for oral administration of the present invention, every day 3 times, and each 100-150ml, 30---60 days is a course of treatment, the careful estrogen of using of forbidding during taking avoids pungent food and drinks; Matched group uses general antiinflammatory, hemostasis that muscular tumor is treated
Efficacy assessment standard: produce effects, menstrual cycle is normal, reduces in 50-100ml through amount, does not have the soreness of waist lumbago menstrual period, and the leucorrhea amount is few, and hysteromyoma dwindles or disappears; Effectively, menstrual cycle is normal, reduces in 50-100ml through amount, and menstrual period, soreness of waist lumbago alleviated, and hysteromyoma does not increase; Invalid, disease is the same, does not have to change.
Result of the test: test group 150 examples, produce effects 97 examples, effective 27 examples, invalid 26 examples, total effective rate is 82.67%; Matched group 60 examples, produce effects 36 examples, effective 8 examples, invalid 16 examples, total effective rate 73.33%.There were significant differences for two groups of total effectses, and the test group clinical effectiveness is apparently higher than matched group.
Medical record is given an example:
1, Liu, woman, 35 years old, Fuhai County, Xinjiang individuality was gone to a doctor on November 17th, 2002, and main suit's menorrhagia 7 years is surplus, nearly January, menstruation more than 20 day is unclean, companion's soreness of waist stomachache, and woman's inspection: vulvovaginal is normal, the uterus is normal, anteversion of uterus increases as sub more than 50 day, and the matter crust has uneven sense, does B ultrasonic, anterior uterine wall muscular tumor (2.4 * 2.7cm), use medicinal preparation for oral administration of the present invention after 7 days, colporrhagia stops, and soreness of waist stomachache takes a turn for the better, 2 courses of treatment of after treatment, pass through the eumenorrhea once more, no soreness of waist stomachache, the leucorrhea amount is few.B ultrasonic check after half a year, the uterus is big slightly, does not see muscular tumor, inquiry, menstrual blood volume does not normally have other discomfort.
2, Shen, woman, 49 years old, the workman of Xinjiang Bei Tun woollen mill, in the prescription on individual diagnosis on the 13rd of calendar year 2001 JIUYUE, the main suit suffers from hysteromyoma for many years, in the past the eumenorrhea, it is many or dripping unclean through measuring that blood appears in nearly half a year, and last menstrual period is unclean so far August 19, companion's shallow complexion, spirit is poor, and is dizzy nervous, soreness of waist stomachache, the leucorrhea amount is many, ultrasound diagnosis: hysteromyoma 4 * 3.7cm, use medicinal preparation for oral administration of the present invention after 8 days, colporrhagia stops, 2 courses of treatment of after treatment, eumenorrhea, soreness of waist stomachache, the leucorrhea amount to disappear, and follows up a case by regular visits to after half a year, menopause, ultrasound diagnosis: hysteromyoma dwindles 3 * 2.1cm.
Four, the specific embodiment
Take by weighing raw material (gram) by following proportioning:
Fructus Rosae Laevigatae 30 Herba Scutellariae Barbataes 15 Ramulus Cinnamomi 20 Halloysitum Rubrums 20 Herba Leonuris 30
Poria 15 Concha Ostreae 45 Spica Prunellaes 30 rhizoma sparganic 20 Herba Artemisiae Anomalaes 30
Wide crust halberd 15 Radix Rubiaes 10 river cattle sunset, 10 Cornu Cervi Degelatinatums, 20 Rhizoma Curcumae 20
Production method is: above-mentioned substance is immersed in the water of 1500-3000 milliliter 2-3 hour; After the immersion, after the decoction boiling for the first time, slow fire continues to decoct extracting juice after 30 minutes; After adding for the second time 500 milliliters of decoction boilings of water, slow fire continues to decoct extracting juice after 30 minutes; With the about 1000 milliliters of mixing of twice decoction medicinal liquid, through distilling, reflux, filter, clarifying, get the bottling of supernatant autoclaving, make oral liquid.
Claims (5)
1. a medicine for the treatment of hysteromyoma is characterized in that it is the medicament of being made by following raw materials by weight proportions
Fructus Rosae Laevigatae 30---45 Herba Scutellariae Barbatae 15---30 Ramulus Cinnamomi 18---25
Halloysitum Rubrum 20---30 Herba Leonuri 15---30 Poria 15---20
Concha Ostreae 45---60 Spica Prunellae 15---30 rhizoma sparganic 10---20
Herba Artemisiae Anomalae 15---30 extensively clings to halberd 10---15 Radix Rubiae 10---15
River cattle sunset 10---15 Cornu Cervi Degelatinatum 10---20 Rhizoma Curcumae 15---20.
2. the medicine of treatment hysteromyoma according to claim 1 is characterized in that said medicament is a said dosage form on any pharmaceutics.
3. the medicine of treatment hysteromyoma according to claim 2 is characterized in that said medicament is tablet, electuary or pill.
4. the medicine of treatment hysteromyoma according to claim 2 is characterized in that said medicament is an oral liquid.
5. the preparation method of the medicine of the described treatment hysteromyoma of claim 4 is characterized in that: with Fructus Rosae Laevigatae, Herba Scutellariae Barbatae, Ramulus Cinnamomi, Halloysitum Rubrum, Herba Leonuri, Poria, Concha Ostreae, Spica Prunellae, rhizoma sparganic, Herba Artemisiae Anomalae, extensively cling to halberd, Radix Rubiae, river Niu Xi, Cornu Cervi Degelatinatum, Rhizoma Curcumae and be soaked in water 2-3 hour; After the immersion, after the decoction boiling for the first time, slow fire continues to decoct extracting juice after 30 minutes; After for the second time decocting with water boiling, slow fire continues to decoct extracting juice after 30 minutes; Twice decoction medicinal liquid mixed,, get the bottling of supernatant autoclaving, make oral liquid through distillation, backflow, filtration, clarification.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100320167A CN100415283C (en) | 2004-03-26 | 2004-03-26 | Medicine for resisting inflammation, contracting uterus and eliminating tumor and its prepn process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100320167A CN100415283C (en) | 2004-03-26 | 2004-03-26 | Medicine for resisting inflammation, contracting uterus and eliminating tumor and its prepn process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1672725A CN1672725A (en) | 2005-09-28 |
| CN100415283C true CN100415283C (en) | 2008-09-03 |
Family
ID=35045667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100320167A Expired - Fee Related CN100415283C (en) | 2004-03-26 | 2004-03-26 | Medicine for resisting inflammation, contracting uterus and eliminating tumor and its prepn process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100415283C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103330893B (en) * | 2013-07-25 | 2014-08-27 | 桑艳萍 | Gynecological menstrual function-regulating and blood-nourishing capsule |
| CN105749166A (en) * | 2016-04-12 | 2016-07-13 | 刘昌红 | Traditional Chinese medicine composition for treating uterine fibroid |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1125613A (en) * | 1995-09-12 | 1996-07-03 | 王桂兰 | Prescription for treatment of hysteromyoma |
-
2004
- 2004-03-26 CN CNB2004100320167A patent/CN100415283C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1125613A (en) * | 1995-09-12 | 1996-07-03 | 王桂兰 | Prescription for treatment of hysteromyoma |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1672725A (en) | 2005-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1061854C (en) | Medicinal preparation for treatment and prevention of gynopathy | |
| CN100563690C (en) | A kind of medicine for the treatment of rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and disease of proplapse of lumbar intervertebral disc | |
| CN103933353A (en) | Medicament for treating rheumatism and gout | |
| CN102688420B (en) | Traditional Chinese medicine decoction for treating psoriasis | |
| CN102698207A (en) | Traditional Chinese medicine composition for treating hepatopathy and preparation method thereof | |
| CN103948782A (en) | Pharmaceutical composition for treating hyperplasia of mammary glands due to stagnation of liver qi as well as preparation method and application of pharmaceutical composition | |
| CN103301353B (en) | Pharmaceutical composition for treating atrophic vaginitis | |
| CN102526635A (en) | Medicament for treating premenstrual stress syndrome and preparation method thereof | |
| CN100415283C (en) | Medicine for resisting inflammation, contracting uterus and eliminating tumor and its prepn process | |
| CN103610685A (en) | Traditional Chinese medicinal composition for treating dysmenorrhea | |
| CN101708300A (en) | Medicinal composition for treating scrofula, hyperplasia of mammary glands and benign lymphadenoma | |
| CN101590208B (en) | Medicament composition for treating rheumatoid arthritis, and preparation method thereof | |
| Jang et al. | Therapeutic effects of Chiljehyangbuhwan on primary dysmenorrhea: A randomized, double blind, placebo-controlled study | |
| CN103610741A (en) | Traditional Chinese medicinal composition for treating spermatorrhea | |
| CN116211987B (en) | Traditional Chinese medicine composition for treating refractory endocrine drug-resistant breast cancer, traditional Chinese medicine preparation and application thereof | |
| CN103301374B (en) | Pharmaceutical composition for treating postpartum non-specificity vaginitis | |
| CN103330896B (en) | Preparation method of powder for treating postpartum nonspecific vaginitis | |
| CN106266152A (en) | A kind of pharmaceutical composition treating eczema and its production and use | |
| CN113491739B (en) | Pain-relieving and stasis-eliminating traditional Chinese medicine for treating endometriosis and preparation method thereof | |
| CN108114234A (en) | Drug of anti-inflammatory uterus contracting tumor eliminating and preparation method thereof | |
| CN1281265C (en) | Diuretic and menstruation-regulating medicine and its prepn | |
| CN105079327A (en) | Traditional Chinese medicine composition for treating amenorrhea | |
| CN101024029A (en) | Medicine for treating bony arthritis, rheumatism arthritis | |
| CN105031552A (en) | Traditional Chinese medicine composition for treating gynecological tumors | |
| CN103623237B (en) | A kind ofly treat Chinese medicine preparation of deficiency-heat type metrorrhagia and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080903 |